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Abstract Ovocleidin, a major protein of the avian eggshell
calcified layer, occurs in the eggshell soluble organic matrix in at
least two forms. The major form is a phosphoprotein with two
phosphorylated serines (OC-17) which was sequenced recently. A
minor form is a glycosylated protein with identical sequence and
only one phosphorylated serine (OC-23). The site of glycosyla-
tion is Asn59, the only asparagine in the amino acid sequence
contained in the N-glycosylation site consensus sequence, N-A-S.
Ser61, which is part of this site, is phosphorylated in OC-17 but
not in OC-23 indicating that the two modifications are mutually
exclusive. This is the first example of alternative glycosylation/
phosphorylation occurring at an N-glycosylation site.
z 1999 Federation of European Biochemical Societies.
Key words: Ovocleidin; Eggshell ; Glycosylation;
Phosphorylation
1. Introduction
The avian eggshell consists of three layers: the most inter-
nal shell membranes which contain collagens as major com-
ponents, the intermediate calci¢ed zone and the outermost
cuticle [1,2]. Electron microscopic analysis of the shell has
shown the calci¢ed layer to consist of at least two compo-
nents, the V100 Wm thick mamillary layer which is in close
contact to the shell membranes and is thought to provide the
starting sites for calci¢cation, and the V300 Wm thick pali-
sade or crystalline layer, the thickest layer of the shell. The
organic matrix of this layer can be isolated after decalci¢ca-
tion. A major component of the soluble fraction of the matrix
is a protein with Mr V17 000 called ovocleidin 17 (OC-17) [3].
This protein is produced by cells of the shell gland mucosa,
tends to form larger aggregates and has been shown by im-
munohistochemical methods to be localised in the calci¢ed
layer. It consists of 142 amino acids including two phospho-
rylated serines [4]. The amino acid sequence forms a single
C-type animal lectin domain and is signi¢cantly similar to a
group of pancreas proteins, the pancreatic stone protein (lith-
ostathin) and pancreatitis-associated proteins. Here we report
the isolation of a glycosylated form of ovocleidin (OC-23) and
the identi¢cation of the glycosylation site.
2. Materials and methods
2.1. Isolation of ovocleidins
Eggshells were treated with 5% EDTA for 30 min at 4^6‡C to
facilitate membrane removal. The powdered calci¢ed layer was ex-
tracted with 10% acetic acid as described [4]. The extract was centri-
fuged at 14 000Ugav for 1 h at 4‡C. The supernatant was dialysed
against 5U10 vol. of 5% acetic acid. The slightly turbid solution was
lyophilised. For HPLC on a Vydac C4 reversed phase column
(50U4.6 mm) the lyophilised protein mixture was suspended in 10%
acetic acid, centrifuged, ¢ltered [4] and the soluble proteins were sep-
arated using a gradient of 14^46% acetonitrile in 0.1% tri£uoroacetic
acid in 40 min at a £ow rate of 0.5 ml/min. The ovocleidin-containing
fractions from C4 reversed phase HPLC runs were dried and dissolved
in 0.1 M ammonium acetate bu¡er, pH 5, containing 4 M guanidi-
nium and chromatographed on two TSK SWXL 2000 columns
(300U7.8 mm) connected in tandem using the same bu¡er at a £ow
rate of 0.3 ml/min. The separated proteins were dialysed against 5%
acetic acid and lyophilised.
2.2. Analytical methods
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) [5] was per-
formed using 10^15% polyacrylamide gradient gels. Amino acid and
hexosamine analyses were done on a Biotronik LC3000 after hydrol-
ysis at 110‡C in 6 M HCl for 20 h and 3 M HCl for 8 h, respectively.
Carboxymethylation, cleavage with chymotrypsin, separation of the
peptides, blotting onto polyvinylidene di£uoride (PVDF) membrane
and sequence analysis were done as previously described [4,6]. Pro-
tein-bound phosphate was determined using a malachite green assay
[7] with 1 h hydrolysis at 60‡C with ribonuclease A as a negative
control. OC-17, which has been shown by amino acid sequence anal-
ysis and mass spectrometry to contain two phosphoserines [4], was
used as a positive control. The amount of protein was determined by
amino acid analysis as above. Automated Edman degradation was
performed on an Applied Biosystems sequencer model 473A. Degly-
cosylation was done with peptide N-glycosidase F (Boehringer Mann-
heim) in 0.05 M sodium phosphate bu¡er, pH 8, containing 10 mM
EDTA and 10 mM phenylmethylsulphonyl £uoride for 24 h at 23‡C
using 1 U/10 Wg of carboxymethylated protein or 5 nmol of peptide.
3. Results and discussion
3.1. Isolation of ovocleidins
Ovocleidin was isolated from decalci¢ed chicken eggshells
as described [4] with the modi¢cation that dialysis was against
5% acetic acid, which prevented the precipitation of ovoclei-
din previously described with dialysis against water. Concom-
itantly, a protein band with Mr V23 000 and strong tailing,
which had occurred only in small amounts in previous prep-
arations, became more prominent in the ovocleidin pool ob-
tained after reversed phase HPLC (Fig. 1). N-terminal amino
acid sequence analysis of this protein (henceforth termed OC-
23) blotted onto PVDF membrane after SDS-PAGE showed
that it had the same N-terminal sequence as the major form of
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ovocleidin described previously [4]. Reversed phase HPLC on
a short C4 column was used to enrich both forms of ovoclei-
din which appeared in the same broad peak with a slight
enrichment of the larger form in the front fractions. The
two forms of the protein were separated from each other
and the remaining other proteins by size exclusion HPLC in
a denaturing solvent (Fig. 2). The ratio of the larger to the
smaller form was estimated to be 1:10 by comparison of the
peak areas. OC-23, but not OC-17, was degraded partially by
contaminating protease(s) when kept in denaturing solvent
around pH 7. Bu¡ering at pH 5 decreased this degradation
and was used for size exclusion chromatography. To further
minimise degradation, the samples were dissolved immediately
before this puri¢cation step and dialysed against 5% acetic
acid immediately after separation. Smaller fragments were re-
moved by rechromatography after carboxymethylation of the
protein (Fig. 1). The yield of OC-23 was 2^4 Wg/g of eggshell
powder. Amino acid analysis and hexosamine analysis showed
that OC-23 had the same amino acid composition (later con-
¢rmed by sequence analysis) as OC-17 but contained in addi-
tion 3^4 glucosamines (3.4 þ 0.6) and 1 galactosamine
(1.1 þ 0.3) per polypeptide chain (mean of two analyses þ max-
imal deviation) demonstrating that the di¡erent mobility in
SDS-PAGE was due to glycosylation of site(s) which had
not been modi¢ed in the major form of the protein. A mo-
lybdate/malachite green assay for phosphate after alkaline
hydrolysis yielded 2.9 þ 0.5 phosphates/polypeptide chain for
OC-17 and 1.5 þ 0.1 for OC-23 (mean of ¢ve determinations
þ S.D.). The previous sequence analysis of OC-17 [4] had
shown the presence of two phosphates/protein molecule indi-
cating that the values found by the colour assay were too high
for unknown reasons. Nevertheless, the data clearly indicated
that OC-23 was a phosphoprotein and that it contained only
half the amount of protein-bound phosphate as compared to
OC-17.
3.2. Determination of the glycosylation site
While galactosamine is in most cases indicative of O-glyco-
sylation of a protein, the presence of an N-glycan could not be
ruled out from the experimentally determined ratio of galac-
tosamine to glucosamine. Deglycosylation of OC-23 with pep-
tide N-glycosidase F decreased the Mr of this form of ovo-
cleidin to the Mr of OC-17 (Fig. 1) indicating that the
carbohydrate was bound to asparagine. The amino acid se-
quence of ovocleidin contains only two asparagines, Asn59
and Asn134 [4]. Only one of them, Asn59, was found in a
typical N-glycosylation site consensus sequence, N-X-T/S.
However, in the non-glycosylated form of ovocleidin Ser61,
which was part of this site, has been identi¢ed as one of the
two phosphoserines of the protein [4]. To identify the possible
site of N-glycosylation experimentally, the reduced and car-
boxymethylated protein was cleaved with chymotrypsin, the
peptides separated by size exclusion chromatography on a
Superdex Peptide column and by reversed phase HPLC using
a C18 column, and then subjected to Edman sequence analysis
[4]. The only peptide which showed di¡erences compared to
the corresponding sequences of OC-17 started at Arg52 and
ended at Trp76 : Asn59 was not observed during sequence anal-
ysis and Ser61, which was phosphorylated in the non-glyco-
sylated protein, was detected in a concentration comparable
to that of surrounding residues indicating that it was not
phosphorylated. When this peptide was treated with peptide
N-glycosidase F, rechromatographed and sequenced again,
position 59 was determined to be aspartic acid. Together these
Fig. 1. Puri¢cation of ovocleidin monitored by PAGE. Lane 1,
whole extract; lane 2, ovocleidin mixture after C4 reversed phase
chromatography; lane 3, glycosylated ovocleidin (OC-23) after size
exclusion chromatography (Fig. 2, peak A); lane 4, carboxymeth-
ylated OC-23 after rechromatography; lane 5, OC-23 after deglyco-
sylation with peptide N-glycosidase F. The position of marker pro-
teins is indicated in kDa at the left.
Fig. 2. Separation of the ovocleidin forms. OC-23 (peak A) was sep-
arated from OC-17 (peak B) by size exclusion chromatography at
pH 5 in 4 M guanidinium. The peak areas were approximately
1:10.
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results identi¢ed Asn59 as an N-glycosylation site. Because
Ser61, which also formed part of the glycosylation site, was
not phosphorylated, glycosylation of Asn59 and phosphoryla-
tion of Ser61 were apparently mutually exclusive.
Alternative glycosylation/phosphorylation is known to oc-
cur in many nuclear and cytoskeletal proteins [8] but at
present has not been observed in extracellular proteins. In
intracellular proteins this modi¢cation can involve O-glycosyl-
ation or alternative phosphorylation of a single serine [9,10] or
residues in the close vicinity [11]. Ovocleidin seems to be the
¢rst example for the alternative glycosylation/phosphorylation
of a protein involving N-glycosylation of an asparagine and
alternative phosphorylation of the corresponding hydroxy-
amino acid forming an N-glycosylation sequon, N-X-T/S. Be-
cause N-glycosylation at such sites occurs only in extracellular
proteins, this type of competitive posttranslational modi¢ca-
tion must be con¢ned to extracellular proteins. N-Glycosyl-
ation is a very early event taking place cotranslationally in the
endoplasmic reticulum. A direct competition between glyco-
sylation and phosphorylation of ovocleidin would require a
kinase in the same compartment. For many extracellular
phosphoproteins the cellular location of the phosphorylation
is not known. An exception is casein which has been reported
to be phosphorylated in the Golgi apparatus of mammary
gland cells of lactating mammals [12,13]. Furthermore, a
casein kinase-like activity has been identi¢ed in the endoplas-
mic reticulum of cells producing dentin phosphoproteins and
it has been proposed that phosphorylation of these extracel-
lular proteins was a cotranslational event [14,15]. Therefore it
may not be too far-fetched to suppose the presence of a kinase
in the endoplasmic reticulum of chicken shell gland cells
which produce ovocleidin.
While the presence of glucosamine in ovocleidin has not
been reported, galactosamine has been identi¢ed using biotin-
ylated lectins [3]. However, this was done with OC-17, which
according to the sequencing results [4] was not glycosylated.
Possibly these preparations contained glycosylated fragments
of OC-23 with the same relative mobility as OC-17. The pres-
ence of galactosamine usually indicates O-glycosylation of a
protein. However, sequence analysis of a set of peptides cover-
ing the entire sequence of ovocleidin showed only two modi-
¢ed amino acids identi¢ed by the lack of a detectable PTH-
amino acid signal in the respective sequencing cycles. These
were the glycosylated Asn59 and the amino acid at position 61
of the ovocleidin sequence. The latter amino acid has been
identi¢ed as phosphoserine in OC-17 by mass spectrometry
[4]. Interestingly the sequence adjacent to this serine was iden-
tical to a recognition signal sequence for the attachment of
glycosaminoglycans in some proteoglycan core proteins, D/E-
X-S-G-X-G [16]. Although this signal was not used in OC-17
and OC-23, one cannot exclude the possibility that it may be
used in other forms of ovocleidin. The presence of phosphate
in OC-23 and the mobility shift in PAGE to the position of
OC-17 after treatment with peptide N-glycosidase F may in-
dicate that this amino acid is also phosphoserine in OC-23.
Therefore, OC-23 may belong to a small group of proteins
which have been shown to contain galactosamine (or rather
N-acetylgalactosamine which is converted to galactosamine by
hydrolysis) in their N-glycan. Other examples are bovine lac-
totransferrin [17], the snake venom enzyme batroxobin [18]
and human urinary kallidinogenase [19]. OC-17 is apparently
not derived from OC-23 because hydrolytic glycosidases con-
vert glycosylated asparagine into aspartic acid. But OC-17 has
asparagine in its N-glycosylation sequon. These data suggest
that ovocleidin is alternatively modi¢ed and that these two
forms of the protein may play di¡erent roles in the construc-
tion of the eggshell.
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